Logo image of IPGP

IPG PHOTONICS CORP (IPGP) Stock Fundamental Analysis

USA - NASDAQ:IPGP - US44980X1090 - Common Stock

85.42 USD
-2.64 (-3%)
Last: 10/22/2025, 8:00:02 PM
85.42 USD
0 (0%)
After Hours: 10/22/2025, 8:00:02 PM
Fundamental Rating

4

IPGP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 123 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for IPGP as it has an excellent financial health rating, but there are worries on the profitability. IPGP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year IPGP was profitable.
In the past year IPGP had a positive cash flow from operations.
Of the past 5 years IPGP 4 years were profitable.
IPGP had a positive operating cash flow in each of the past 5 years.
IPGP Yearly Net Income VS EBIT VS OCF VS FCFIPGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

IPGP has a worse Return On Assets (-9.05%) than 63.41% of its industry peers.
Looking at the Return On Equity, with a value of -10.24%, IPGP is doing worse than 61.79% of the companies in the same industry.
Industry RankSector Rank
ROA -9.05%
ROE -10.24%
ROIC N/A
ROA(3y)1.4%
ROA(5y)3.68%
ROE(3y)1.57%
ROE(5y)4.2%
ROIC(3y)N/A
ROIC(5y)N/A
IPGP Yearly ROA, ROE, ROICIPGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

In the last couple of years the Operating Margin of IPGP has declined.
With a Gross Margin value of 34.65%, IPGP perfoms like the industry average, outperforming 56.10% of the companies in the same industry.
IPGP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IPGP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.65%
OM growth 3Y-60.56%
OM growth 5Y-41.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-5.58%
IPGP Yearly Profit, Operating, Gross MarginsIPGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

9

2. Health

2.1 Basic Checks

IPGP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IPGP has been reduced compared to 1 year ago.
The number of shares outstanding for IPGP has been reduced compared to 5 years ago.
IPGP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IPGP Yearly Shares OutstandingIPGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IPGP Yearly Total Debt VS Total AssetsIPGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 10.44 indicates that IPGP is not in any danger for bankruptcy at the moment.
IPGP has a better Altman-Z score (10.44) than 87.80% of its industry peers.
IPGP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.44
ROIC/WACCN/A
WACC9.1%
IPGP Yearly LT Debt VS Equity VS FCFIPGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

IPGP has a Current Ratio of 6.79. This indicates that IPGP is financially healthy and has no problem in meeting its short term obligations.
IPGP's Current ratio of 6.79 is amongst the best of the industry. IPGP outperforms 89.43% of its industry peers.
A Quick Ratio of 5.39 indicates that IPGP has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.39, IPGP belongs to the top of the industry, outperforming 86.99% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.79
Quick Ratio 5.39
IPGP Yearly Current Assets VS Current LiabilitesIPGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

The earnings per share for IPGP have decreased strongly by -76.16% in the last year.
The earnings per share for IPGP have been decreasing by -19.50% on average. This is quite bad
IPGP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.77%.
Measured over the past years, IPGP shows a decrease in Revenue. The Revenue has been decreasing by -5.76% on average per year.
EPS 1Y (TTM)-76.16%
EPS 3Y-34.65%
EPS 5Y-19.5%
EPS Q2Q%-64.44%
Revenue 1Y (TTM)-14.77%
Revenue growth 3Y-12.55%
Revenue growth 5Y-5.76%
Sales Q2Q%-2.69%

3.2 Future

IPGP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.39% yearly.
IPGP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.17% yearly.
EPS Next Y-51.79%
EPS Next 2Y4.34%
EPS Next 3Y17.39%
EPS Next 5YN/A
Revenue Next Year-1.15%
Revenue Next 2Y2.95%
Revenue Next 3Y3.83%
Revenue Next 5Y7.17%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IPGP Yearly Revenue VS EstimatesIPGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
IPGP Yearly EPS VS EstimatesIPGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 118.64, the valuation of IPGP can be described as expensive.
IPGP's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.57. IPGP is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 54.49, which means the current valuation is very expensive for IPGP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IPGP is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of IPGP to the average of the S&P500 Index (23.09), we can say IPGP is valued expensively.
Industry RankSector Rank
PE 118.64
Fwd PE 54.49
IPGP Price Earnings VS Forward Price EarningsIPGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

IPGP's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IPGP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 55.79
EV/EBITDA 39.82
IPGP Per share dataIPGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

IPGP's earnings are expected to grow with 17.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.34%
EPS Next 3Y17.39%

0

5. Dividend

5.1 Amount

No dividends for IPGP!.
Industry RankSector Rank
Dividend Yield N/A

IPG PHOTONICS CORP

NASDAQ:IPGP (10/22/2025, 8:00:02 PM)

After market: 85.42 0 (0%)

85.42

-2.64 (-3%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners70.07%
Inst Owner Change0.05%
Ins Owners6.4%
Ins Owner Change-1.3%
Market Cap3.61B
Revenue(TTM)945.99M
Net Income(TTM)-215416000
Analysts72.5
Price Target81.8 (-4.24%)
Short Float %9.64%
Short Ratio9.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.22%
Min EPS beat(2)-57.53%
Max EPS beat(2)69.97%
EPS beat(4)2
Avg EPS beat(4)11.01%
Min EPS beat(4)-57.53%
Max EPS beat(4)69.97%
EPS beat(8)4
Avg EPS beat(8)5.09%
EPS beat(12)8
Avg EPS beat(12)8.18%
EPS beat(16)10
Avg EPS beat(16)8.23%
Revenue beat(2)1
Avg Revenue beat(2)2.7%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)7.06%
Revenue beat(4)3
Avg Revenue beat(4)1.68%
Min Revenue beat(4)-1.67%
Max Revenue beat(4)7.06%
Revenue beat(8)4
Avg Revenue beat(8)-0.25%
Revenue beat(12)6
Avg Revenue beat(12)-0.61%
Revenue beat(16)9
Avg Revenue beat(16)0.1%
PT rev (1m)0%
PT rev (3m)20.78%
EPS NQ rev (1m)-4.1%
EPS NQ rev (3m)-25.24%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-27.88%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.46%
Valuation
Industry RankSector Rank
PE 118.64
Fwd PE 54.49
P/S 3.81
P/FCF 55.79
P/OCF 23.87
P/B 1.71
P/tB 1.82
EV/EBITDA 39.82
EPS(TTM)0.72
EY0.84%
EPS(NY)1.57
Fwd EY1.84%
FCF(TTM)1.53
FCFY1.79%
OCF(TTM)3.58
OCFY4.19%
SpS22.41
BVpS49.85
TBVpS46.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number28.42
Profitability
Industry RankSector Rank
ROA -9.05%
ROE -10.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.65%
FCFM 6.83%
ROA(3y)1.4%
ROA(5y)3.68%
ROE(3y)1.57%
ROE(5y)4.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.46%
ROCE(5y)8.05%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-60.56%
OM growth 5Y-41.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-5.58%
F-Score4
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 141.45%
Cap/Sales 9.14%
Interest Coverage N/A
Cash Conversion 277.64%
Profit Quality N/A
Current Ratio 6.79
Quick Ratio 5.39
Altman-Z 10.44
F-Score4
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)146.85%
Cap/Depr(5y)132.22%
Cap/Sales(3y)8.79%
Cap/Sales(5y)8.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.16%
EPS 3Y-34.65%
EPS 5Y-19.5%
EPS Q2Q%-64.44%
EPS Next Y-51.79%
EPS Next 2Y4.34%
EPS Next 3Y17.39%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.77%
Revenue growth 3Y-12.55%
Revenue growth 5Y-5.76%
Sales Q2Q%-2.69%
Revenue Next Year-1.15%
Revenue Next 2Y2.95%
Revenue Next 3Y3.83%
Revenue Next 5Y7.17%
EBIT growth 1Y-105.93%
EBIT growth 3Y-65.51%
EBIT growth 5Y-45.12%
EBIT Next Year158.96%
EBIT Next 3Y43.07%
EBIT Next 5Y28.3%
FCF growth 1Y-42.28%
FCF growth 3Y-17.56%
FCF growth 5Y-4.7%
OCF growth 1Y-31.73%
OCF growth 3Y-14%
OCF growth 5Y-5.18%